Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

Nat Immunol. 2020 Jan;21(1):101. doi: 10.1038/s41590-019-0554-3.

¹ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
² Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA.
³ Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
⁴ Department of Research Bioinformatics, MedImmune LLC, Gaithersburg, MD, USA.
⁵ Autoimmunity, Transplantation, and Inflammation Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
⁶ Department of Oncogenomics, Academic Medical Center, Amsterdam, the Netherlands.
⁷ Department of Translational Medicine and Pharmacogenomics, MedImmune LLC, Gaithersburg, MD, USA.
⁸ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. hergen.spits@amc.uva.nl.
⁹ Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA. alisonhumbles@gmail.com.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.